PROFITS AND PLAGIARISM: THE CASE OF MEDICAL GHOSTWRITING
This paper focuses on medical ghostwriting in the United States. I argue that medical ghostwriting often involves plagiarism and, in those cases, can be treated as an act of research misconduct by both the federal government and research institutions. I also propose several anti-ghostwriting measure...
| Autor principal: | |
|---|---|
| Tipo de documento: | Electrónico Artículo |
| Lenguaje: | Inglés |
| Verificar disponibilidad: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Publicado: |
2010
|
| En: |
Bioethics
Año: 2010, Volumen: 24, Número: 6, Páginas: 267-272 |
| Otras palabras clave: | B
ghostwriting
B Salud pública B Plagiarism B honorary authors B research misconduct B Medical Ethics B pharmaceutical companies |
| Acceso en línea: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
| Sumario: | This paper focuses on medical ghostwriting in the United States. I argue that medical ghostwriting often involves plagiarism and, in those cases, can be treated as an act of research misconduct by both the federal government and research institutions. I also propose several anti-ghostwriting measures, including: 1) journals should implement guarantor policies so that researchers may be better held accountable for their work; 2) research institutions and the federal government should explicitly prohibit medical ghostwriting and outline appropriate penalties; and 3) a publicly available database should be created to record researchers' ethics violations. |
|---|---|
| ISSN: | 1467-8519 |
| Obras secundarias: | Enthalten in: Bioethics
|
| Persistent identifiers: | DOI: 10.1111/j.1467-8519.2008.00705.x |
